Medlink for Diagnosing of Diabetes Mellitus, COPD, CHF, Myasthenia Gravis and Hypertension
Phase: NA
Conditions: Diabetes Mellitus, Chronic Obstructive Pulmonary Disease, Congestive Heart Failure, Myasthenia Gravis, Hypertension
Sponsor: Olawuyi Racett Nigeria Ltd

 
OLAWUYI RACETT NIGERIA LTD. WELLINGTON SQUARE, OXFORD, OX1 2JD, 
UNITED KINGDOM RC14668218 
 
 
STUDY SUMMARY 
 
MEDLINK is a pocket-sized, verbally interactive, programmable medical device that 
allows physicians to select which medical measurements they would like to take for a specific 
patient. The Physiological Parameters that can be measured by MEDLINK include, but is not 
limited to: Electrocardiography (ECG), Blood Pressure, Heart Rate, Blood Glucose, Pulse Rate, 
Blood Oxygen Saturation (SPO2), Electromyography (EMG) body temperature, and Respiratory 
Data. After programming of the device by the Physician, MEDLINK can be given to the desired 
patient to take home for Remote Patient Monitoring (RPM).  
 
When the patient switches on the device at home, MEDLINK verbally guides the patient 
to acquire the measurements requested by his or her Physician. This information is 
automatically and wirelessly transmitted to the Physician’s Mobile Phone and Email Address for 
medical analysis, check up, and/or follow up. MEDLINK has its own software application that 
allows the Physician to view and analyse the measured Physiological Parameters for any 
Patient. MEDLINK also has the potential to allow Patient-Physician Communication during the 
RPM Period. 
 
One of the key innovations of MEDLINK is that it is able to acquire a diverse range of 
physiological parameters. This makes it useful to physicians in different areas of specialization 
in the medical field. In addition to this, MEDLINK also accurately measures all Physiological 
Parameters of the Patient through a single digit finger being inserted into the appropriate 
position in the pocket-device, making it extremely easy to use. MEDLINK is the first medical 
device that performs blood glucose measurement using Infrared Technology, as opposed to the 
standardized lancet finger-pricking technology. 
MEDLINK allows Physicians in any specialization to monitor patients outside of the 
hospital setting for as long as is needed. It can be used to monitor patients after they have been 
discharged from the hospital. It also allows individuals to have quality access to basic health 
care. Once programmed by a Physician and given to an individual, MEDLINK can be used to 
provide regular health care check up and coverage for the individual for as long as they want, 
and so in this sense provides basic health coverage for the individual. 
During Physician Programming of the device, MEDLINK collects the patient's information 
by verbally interacting with the Physician to obtain them. Once this is done, MEDLINK takes the 

patient's measurements and transmits them to the Physician when it is used by the patient. 
MEDLINK does abide by the US HIPAA Regulations by transmitting the Patient’s ID, known by 
the Requesting Physician ONLY, and so the patient's identity is concealed from everyone 
except the Physician to whom the Patient is seeking medical coverage from.  
To our knowledge, MEDLINK is the first portable device that can be used to provide 
RPM coverage by measuring a wide range of Physiological Parameters. Because of this, 
MEDLINK can be easily integrated into the RPM Market in any country regardless of the 
specialization it sits in in the medical field. MEDLINK will increase the use of RPM across the 
medical field, and so will reduce the number and cost of ER visits and hospitalizations, as has 
been proven already.  
The pocket-sized MEDLINK device can be used to provide health care access to those 
with disabilities, because it is easy to use, provides verbal instructions to the user and can be 
operated with the placement of a single finger. It can certainly be used by individuals that are 
unconnected to the medical field and are unable to obtain medical coverage, be it due to their 
remote access location or a lack of a financial means. This is possible because the device is 
remotely operated and requires little input from the Physician to provide access to basic health 
care, and it can be operated by the user from any location they reside in. 
MEDLINK allows for easy Patient-Physician Communication during the Health Care 
Coverage Monitoring period. Not only is it easy for the Patient’s data to be rapidly transmitted to 
the MEDLINK software on the Physician’s phone and/or email, MEDLINK also allows the 
Physicians to send messages to the Patient during the RPM period, informing them that their 
measurements are okay, or requiring them to come to the hospital for further check up if 
abnormalities are detected in their measured data, either by the MEDLINK software, or by the 
Physician himself. Instructions from the Physician to the Patient are relayed verbally by the 
MEDLINK Device to Patient and so effective exchange of information is accomplished. 
OLAWUYI RACETT NIGERIA LTD., UNITED KINGDOM,RC14668218 has been trained 
by the Food and Drug Administration (FDA), and United States Patent and TradeMark Office 
(USPTO) in 2023 on how to conduct Clinical Trials for Medical Products. The USA PATENT for 
MEDLINK has been filed by OLAWUYI RACETT NIGERIA LTD., UNITED KINGDOM 
RC14668218 with the United States Patent and TradeMark Office (USPTO) in 2023 
(www.uspto.gov) 
 
 
IMAGES 
 
 

 

 
 

 
 
 
 
 

 
  
 
 

PARTICIPANT FLOW 
 
 
BASELINE CHARACTERISTICS 
• 
Enrolled 10 Patients Between the Ages of 10-80, both Male and Female. 
 
 
 
PRIMARY OUTCOME MEASURES 
 
 
• 
FEV1: 2.82 Litres 
FVC: 3.51 Litres 
FEV1/FVC Ratio: 0.80 
HEART RATE: 111 
AVERAGE HEART RATE: 113.81 
 
• 
SPO2 - 90% 
Heart Rate - 85.35 
 
• 
SPO2 - 92 % 
Average Heart Rate - 88.65 
 
• 
ECG Output: 
Volts[V]: 1.38 1.32 1.24 1.15 1.07 0.99 0.93 0.87 0.81 0.75 0.70 0.67 0.64 0.61 0.58 
0.58 0.59 0.56 0.53 0.52 0.53 0.58 0.65 0.76 0.90 1.06 1.23 1.39 1.52 1.62 1.73 1.75 
1.71 1.62 1.52 1.37 1.21 1.05 0.91 0.81 0.66 0.49 0.29 0.03 0.00 0.00 0.00 0.00 0.00 
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00  
Note: Each reading is acquired in 1.25ms 
 

 
 
Blood Pressure Readings from IR Glucometer 
165 
169 
168 
167 
167 
167 
Average Blood Glucose: 167.60 
Average Blood Glucose in mmol/L: 5.82 
 
• 
HEART RATE: 68.20 bpm 
Blood Pressure Readings from IR Glucometer 
193 
195 
182 
176 
173 
176 
Average Blood Glucose: 187.40 
Average Blood Glucose in mmol/L: 6.31 
 
 
• 
HEART RATE: 68.95 bpm 
SPO2  93% 
 
• 
PULSE: 74.80 
HEART RATE: 90 
 
• 
SPO2: 96% 
EMG DATA: 
COLLECTION VALUE 1: 1584 
POWER VALUE1: 471 
AVERAGE VALUE 1494 
MUSCLE STRENGTH 1: 0 
COLLECTION VALUE  2: 1 
494 
POWER VALUE 2: 13 
AVERAGE VALUE 2: 1494 
MUSCLE STRENGTH 2:0 
 

• 
HEART RATE: 82 
EMG DATA: 
COLLECTION VALUE 1: 1584 
POWER VALUE1: 471 
AVERAGE VALUE 1494 
MUSCLE STRENGTH 1: 0 
COLLECTION VALUE  2: 1494 
POWER VALUE 2: 13 
AVERAGE VALUE 2: 1494 
MUSCLE STRENGTH 2:0 
 
• 
FEV1: 1.9L  
FVC: 2.5L 
FEV1/FVC RATIO: 80% 
ECG: 3.74V 
 
 
 
 
ADVERSE EVENTS 
There were no adverse events associated with this study.